Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that John Soden has joined the firm’s Healthcare investment banking practice as a ...
Allvue Systems, LLC ("Allvue"), a leading alternative investment technology solutions provider, today announced its selection by Guggenheim Investments to deliver advanced Portfolio Management and ...
Lionpoint Group oversaw the implementation of Allvue's Portfolio Management and Research Management solutions for Guggenheim Investments Allvue Systems, LLC ("Allvue"), a leading alternative investmen ...
The Guggenheim family went on to finance industrial and cultural ... “GB Media is here to complement existing investors and ...
Inc. The fund is co-managed by Guggenheim Partners Investment Management LLC, Concinnity Advisors, LP. It invests in public equity markets of the United States. It invests in stocks of companies ...
Roku Inc (ROKU) stock saw a modest uptick, ending the day at $77.36 which represents a slight increase of $2.69 or 3.60% from the prior close of $74.67. The stock opened at $76.18 and touched a low of ...
Iqvia Holdings Inc (IQV) stock saw a modest uptick, ending the day at $242.67 which represents a slight increase of $2.69 or 1.12% from the prior close of $239.98. The stock opened at $240.85 and ...
Advent Convertible and Income Fund (NYSE: AVK) (the “Fund”) announced updated record and ex-dividend dates for its October Distribution. As previously announced, on September 10, 2024, the Fund ...
Guggenheim Partners CIO Anne Walsh assumed Minerd’s responsibilities and made Steven Brown CIO of fixed income. They continue as managers here along with Adam Bloch and Evan Serdensky ...
Guggenheim Partners CIO Anne Walsh assumed Minerd’s responsibilities and made Steven Brown CIO of fixed income. They continue as managers here along with Adam Bloch and Evan Serdensky ...
Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...
BOSTON and LONDON, Sept. 12, 2024(Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the pricing ...